Palbociclib Plus Letrozole For Postmenopausal Women With HR(+) HER2(-) Advanced Breast Cancer For Whom Letrozole Is Deemed Appropriate
Clinical trial NCT02600923 · COMPLETED
Trial details
- NCT number
- NCT02600923
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-15
- Primary completion
- 2019-05-28
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.